You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 16, April 25, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (139)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Pediatrics
 •Pediatrics, Other
 •Immunization
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage

Rosalyn J. Singleton, MD, MPH; Thomas W. Hennessy, MD, MPH; Lisa R. Bulkow, MS; Laura L. Hammitt, MD; Tammy Zulz, BS; Debby A. Hurlburt, RN; Jay C. Butler, MD; Karen Rudolph, PhD; Alan Parkinson, PhD

JAMA. 2007;297:1784-1792.

Context  With routine childhood vaccination using heptavalent pneumococcal conjugate vaccine, one concern has been the potential for emergence and expansion of replacement disease caused by serotypes not contained in the heptavalent conjugate vaccine.

Objective  To determine whether replacement disease is associated with the overall decline in invasive pneumococcal disease among Alaska Native children.

Design, Setting, and Patients  Alaska statewide longitudinal population-based laboratory surveillance of invasive Streptococcus pneumoniae infections from January 1, 1995, through December 31, 2006.

Main Outcome Measures  Incidence and types of pneumococcal disease in children younger than 2 years.

Results  In the first 3 years after introduction of routine vaccination with heptavalent pneumococcal conjugate vaccine, overall invasive pneumococcal disease decreased 67% in Alaska Native children younger than 2 years (from 403.2 per 100 000 in 1995-2000 to 134.3 per 100 000 per year in 2001-2003, P<.001). However, between 2001-2003 and 2004-2006, there was an 82% increase in invasive disease in Alaska Native children younger than 2 years to 244.6/100 000 (P = .02). Since 2004, the invasive pneumococcal disease rate caused by nonvaccine serotypes has increased 140% compared with the prevaccine period (from 95.1 per 100 000 in 1995-2000 to 228.6 in 2004-2006, P = .001). During the same period, there was a 96% decrease in heptavalent vaccine serotype disease. Serotype 19A accounted for 28.3% of invasive pneumococcal disease among Alaska children younger than 2 years during 2004-2006. There was no significant increase in nonvaccine disease in non–Native Alaska children younger than 2 years.

Conclusions  Alaska Native children are experiencing replacement invasive pneumococcal disease with serotypes not covered by heptavalent pneumococcal conjugate vaccine. The demonstration of replacement invasive pneumococcal disease emphasizes the importance of ongoing surveillance and development of expanded valency vaccines.


Author Affiliations: Arctic Investigations Program, National Center for Preparedness Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention (Drs Singleton, Hennessy, Hammitt, Rudolph, and Parkinson and Mss Bulkow, Zulz, and Hurlburt), Alaska Native Tribal Health Consortium (Drs Singleton and Hammitt), and Alaska Division of Public Health (Dr Butler), Anchorage, Alaska.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Invasive Pneumococcal Disease: The Target Is Moving
Timothy R. Peters and Katherine A. Poehling
JAMA. 2007;297(16):1825-1826.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

PspA Family Fusion Proteins Delivered by Attenuated Salmonella enterica Serovar Typhimurium Extend and Enhance Protection against Streptococcus pneumoniae
Xin et al.
Infect. Immun. 2009;77:4518-4528.
ABSTRACT | FULL TEXT  

Incidence of Invasive Pneumococcal Disease Among Children After Introduction of a 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study in Olmsted County, Minnesota
Tsigrelis et al.
Mayo Clin Proc. 2009;84:871-875.
ABSTRACT | FULL TEXT  

The NanA Neuraminidase of Streptococcus pneumoniae Is Involved in Biofilm Formation
Parker et al.
Infect. Immun. 2009;77:3722-3730.
ABSTRACT | FULL TEXT  

Disappearance of Vaccine-Type Invasive Pneumococcal Disease and Emergence of Serotype 19A in a Minority Population with a High Prevalence of Human Immunodeficiency Virus and Low Childhood Immunization Rates
Tasslimi et al.
CVI 2009;16:1256-1259.
ABSTRACT | FULL TEXT  

Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children: A Randomized Controlled Trial
van Gils et al.
JAMA 2009;302:159-167.
ABSTRACT | FULL TEXT  

Sortase A Confers Protection against Streptococcus pneumoniae in Mice
Gianfaldoni et al.
Infect. Immun. 2009;77:2957-2961.
ABSTRACT | FULL TEXT  

Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Huang et al.
Pediatrics 2009;124:e1-e11.
ABSTRACT | FULL TEXT  

Protection against Pneumococcal Colonization and Fatal Pneumonia by a Trivalent Conjugate of a Fusion Protein with the Cell Wall Polysaccharide
Lu et al.
Infect. Immun. 2009;77:2076-2083.
ABSTRACT | FULL TEXT  

Temporal Trends of Antimicrobial Resistance and Clonality of Invasive Streptococcus pneumoniae Isolates in Finland, 2002 to 2006
Siira et al.
Antimicrob. Agents Chemother. 2009;53:2066-2073.
ABSTRACT | FULL TEXT  

Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants
Stancil et al.
Arch Pediatr Adolesc Med 2009;163:422-425.
ABSTRACT | FULL TEXT  

Impact of Immunizations on the Disease Burden of American Indian and Alaska Native Children
Singleton et al.
Arch Pediatr Adolesc Med 2009;163:446-453.
ABSTRACT | FULL TEXT  

Epidemiology and Risk Factors for Serogroup X Meningococcal Meningitis during an Outbreak in Western Kenya, 2005-2006
Mutonga et al.
Am J Trop Med Hyg 2009;80:619-624.
ABSTRACT | FULL TEXT  

Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007
Fenoll et al.
J. Clin. Microbiol. 2009;47:1012-1020.
ABSTRACT | FULL TEXT  

Bacteriocin Activity of Streptococcus pneumoniae Is Controlled by the Serine Protease HtrA via Posttranscriptional Regulation
Dawid et al.
J. Bacteriol. 2009;191:1509-1518.
ABSTRACT | FULL TEXT  

Role of Conjugative Elements in the Evolution of the Multidrug-Resistant Pandemic Clone Streptococcus pneumoniaeSpain23F ST81
Croucher et al.
J. Bacteriol. 2009;191:1480-1489.
ABSTRACT | FULL TEXT  

Competitive Inhibition Flow Analysis Assay for the Non-Culture-Based Detection and Serotyping of Pneumococcal Capsular Polysaccharide
Findlow et al.
CVI 2009;16:222-229.
ABSTRACT | FULL TEXT  

Age-Specific Cluster of Cases of Serotype 1 Streptococcus pneumoniae Carriage in Remote Indigenous Communities in Australia
Smith-Vaughan et al.
CVI 2009;16:218-221.
ABSTRACT | FULL TEXT  

The controversy over the efficacy of pneumococcal vaccine
Andrews and Moberley
CMAJ 2009;180:18-19.
FULL TEXT  

Pathogens Causing Recurrent and Difficult-to-Treat Acute Otitis Media, 2003-2006
Pichichero et al.
CLIN PEDIATR 2008;47:901-906.
ABSTRACT  

Cross-Sectional Study of Nasopharyngeal Carriage of Streptococcus pneumoniae in Human Immunodeficiency Virus-Infected Adults in the Conjugate Vaccine Era
Onwubiko et al.
J. Clin. Microbiol. 2008;46:3621-3625.
ABSTRACT | FULL TEXT  

Increasing Prevalence of Pneumococcal Serotype 19A Among US Children
Eiland
Journal of Pharmacy Practice 2008;21:356-362.
ABSTRACT  

Severe Cardiovascular and Thromboembolic Consequences of Pneumococcal Infection in a Child
Al-Sabbagh et al.
Pediatrics 2008;122:e945-e947.
ABSTRACT | FULL TEXT  

Phenotypic and Genotypic Characterization of Streptococcus pneumoniae Strains Colonizing Children Attending Day-Care Centers in Norway
Vestrheim et al.
J. Clin. Microbiol. 2008;46:2508-2518.
ABSTRACT | FULL TEXT  

A Second Pilus Type in Streptococcus pneumoniae Is Prevalent in Emerging Serotypes and Mediates Adhesion to Host Cells
Bagnoli et al.
J. Bacteriol. 2008;190:5480-5492.
ABSTRACT | FULL TEXT  

Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding Respiratory Viral Infection
Ampofo et al.
Pediatrics 2008;122:229-237.
ABSTRACT | FULL TEXT  

Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment
Kong et al.
Proc. Natl. Acad. Sci. USA 2008;105:9361-9366.
ABSTRACT | FULL TEXT  

Pneumococcal Mastoiditis in Children and the Emergence of Multidrug-Resistant Serotype 19A Isolates
Ongkasuwan et al.
Pediatrics 2008;122:34-39.
ABSTRACT | FULL TEXT  

Polyclonal Population Structure of Streptococcus pneumoniae Isolates in Spain Carrying mef and mef plus erm(B)
de la Pedrosa et al.
Antimicrob. Agents Chemother. 2008;52:1964-1969.
ABSTRACT | FULL TEXT  

Streptococcus pneumoniae Surface Protein PcpA Elicits Protection against Lung Infection and Fatal Sepsis
Glover et al.
Infect. Immun. 2008;76:2767-2776.
ABSTRACT | FULL TEXT  

Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades
Darrieux et al.
J Med Microbiol 2008;57:273-278.
ABSTRACT | FULL TEXT  

Pneumococcal Vaccination for Patients With COPD: Current Practice and Future Directions
Schenkein et al.
Chest 2008;133:767-774.
ABSTRACT | FULL TEXT  

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies
Giefing et al.
JEM 2008;205:117-131.
ABSTRACT | FULL TEXT  

Emergence of Antimicrobial-Resistant Serotype 19A Streptococcus pneumoniae Massachusetts, 2001-2006
JAMA 2007;298:2612-2614.
FULL TEXT  

Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children
Pichichero and Casey
JAMA 2007;298:1772-1778.
ABSTRACT | FULL TEXT  

Antimicrobial Resistance: It's Not Just for Hospitals
Bancroft
JAMA 2007;298:1803-1804.
FULL TEXT  

Functional Antibodies to the O-Acetylated Pneumococcal Serotype 15B Capsular Polysaccharide Have Low Cross-Reactivities with Serotype 15C
Rajam et al.
CVI 2007;14:1223-1227.
ABSTRACT | FULL TEXT  

Pneumococcal Vaccine: The Good, the Bad, and the Uncertain
JWatch Pediatrics 2007;2007:1-1.
FULL TEXT  

Replacement of Pneumococcal Serotypes After PCV7 Vaccination
JWatch Infect. Diseases 2007;2007:1-1.
FULL TEXT  

Invasive Pneumococcal Disease: The Target Is Moving
Peters and Poehling
JAMA 2007;297:1825-1826.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.